Adicet Bio Inc (ACET)

Adicet Bio Inc (ACET) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $42.4M; returns 1 day -6.8%, 1 week -12.7%, 1 year -71.0%.

Adicet Bio Inc. (ACET) is a clinical-stage biotechnology company focused on the discovery and development of allogeneic (off-the-shelf) gamma delta T cell therapies for the treatment of autoimmune diseases and cancer.

Groups ACET belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Clinical Stage
• Autoimmune Diseases
• Healthcare
• Life Sciences
• Oncology
• Cancer Therapeutics
• Immunotherapy
• Biopharmaceutical

ACET financial model: income statement, cash flow and balance sheet